As per Future Market Insights’ latest study, the global direct-to-consumer genetic testing market stood at genetic testing sold directly to consumers is anticipated to develop at a CAGR of 11.2% from 2022 to 2032 and is projected to reach US$ 4.0 Bn in that year. The market is being led by single nucleotide polymorphism (SNP) chips, which …